Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

TCI Group

This article was originally published in The Gray Sheet

Executive Summary

Self-administered TCI Ovulation Tester receives FDA over-the-counter clearance for detecting the most fertile days of a woman's menstrual cycle by the direct visualization of characteristic peri-ovulatory ferning patterns seen in dried saliva. In clinical trials, saliva ferning on a glass slide could be identified 93% of the time by untrained women using the device's mini-microscope. The test, which produces results in 10 minutes, demonstrated substantial equivalence to Quidel's urine sample-based Conceive ovulation predictor...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT016023

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel